单药治疗-话题@MedSci

#单药治疗#

130篇内容 | 3006人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1687696, encodeId=1ec0168e69689, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Hepatology：乙肝肝移植术后恩替卡韦单药治疗长期预后, objectType=article, longId=94426, objectId=3a4494426e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a4494426e9, replyNumber=0, likeNumber=66, createdTime=2017-08-05, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a4494426e9, moduleTitle=Hepatology：乙肝肝移植术后恩替卡韦单药治疗长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a4494426e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687691, encodeId=d5b2168e691fe, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Opdivo单药治疗晚期肝癌是安全有效的（CheckMate 040）, objectType=article, longId=82634, objectId=30bb82634ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30bb82634ae, replyNumber=0, likeNumber=69, createdTime=2017-08-21, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30bb82634ae, moduleTitle=Opdivo单药治疗晚期肝癌是安全有效的（CheckMate 040）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30bb82634ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687698, encodeId=1ee6168e6982f, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Neurology：Preladenant单药治疗帕金森病III期失败, objectType=article, longId=98504, objectId=7fa2985048c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fa2985048c, replyNumber=0, likeNumber=67, createdTime=2017-07-28, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fa2985048c, moduleTitle=Neurology：Preladenant单药治疗帕金森病III期失败, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fa2985048c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687700, encodeId=c433168e700a8, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Am J Hematol：来那度胺单药治疗复发性/难治性套细胞淋巴瘤，安全且有效, objectType=article, longId=107096, objectId=7f2310e09663, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f2310e09663, replyNumber=0, likeNumber=91, createdTime=2018-06-15, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f2310e09663, moduleTitle=Am J Hematol：来那度胺单药治疗复发性/难治性套细胞淋巴瘤，安全且有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f2310e09663)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687697, encodeId=e591168e697df, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=JAHA：磺脲类和二甲双胍单药治疗对心力衰竭风险的影响！, objectType=article, longId=96855, objectId=3a7f9685500, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a7f9685500, replyNumber=0, likeNumber=77, createdTime=2017-12-27, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a7f9685500, moduleTitle=JAHA：磺脲类和二甲双胍单药治疗对心力衰竭风险的影响！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a7f9685500)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687693, encodeId=308a168e69390, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=UCB抗癫痫药Vimpat获欧盟批准单药治疗部分发作性癫痫，年销售峰值将达到12亿美元, objectType=article, longId=85434, objectId=cd1a854340b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd1a854340b, replyNumber=0, likeNumber=58, createdTime=2017-07-16, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd1a854340b, moduleTitle=UCB抗癫痫药Vimpat获欧盟批准单药治疗部分发作性癫痫，年销售峰值将达到12亿美元, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd1a854340b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687694, encodeId=17be168e69478, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=JCO：nivolumab单药治疗黑色素瘤安全性的Pooled分析, objectType=article, longId=87339, objectId=ea458e339f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea458e339f5, replyNumber=0, likeNumber=55, createdTime=2017-07-23, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea458e339f5, moduleTitle=JCO：nivolumab单药治疗黑色素瘤安全性的Pooled分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea458e339f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687695, encodeId=2510168e695f6, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=LANCET：卡利拉嗪与利培酮单药治疗精神分裂症患者阴性症状的比较, objectType=article, longId=88925, objectId=f51588925b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f51588925b5, replyNumber=0, likeNumber=70, createdTime=2017-05-05, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f51588925b5, moduleTitle=LANCET：卡利拉嗪与利培酮单药治疗精神分裂症患者阴性症状的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f51588925b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687692, encodeId=cda8168e692a7, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Neurology：儿童失神癫痫患者的第二个单药治疗药物有哪些？, objectType=article, longId=84653, objectId=ccfa846530e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ccfa846530e, replyNumber=0, likeNumber=72, createdTime=2017-08-27, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ccfa846530e, moduleTitle=Neurology：儿童失神癫痫患者的第二个单药治疗药物有哪些？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ccfa846530e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687690, encodeId=ef30168e690fc, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Arthritis Res Ther：塔西单抗单药治疗可以作为类风湿关节炎的二线治疗, objectType=article, longId=79030, objectId=d028e9030db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d028e9030db, replyNumber=0, likeNumber=100, createdTime=2017-02-03, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d028e9030db, moduleTitle=Arthritis Res Ther：塔西单抗单药治疗可以作为类风湿关节炎的二线治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d028e9030db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687688, encodeId=11c8168e68802, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Lancet Oncol：Lenvatinib加依维莫司和lenvatinib单药治疗转移性肾细胞癌效果好, objectType=article, longId=57366, objectId=2de45e3662c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2de45e3662c, replyNumber=0, likeNumber=54, createdTime=2016-05-20, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2de45e3662c, moduleTitle=Lancet Oncol：Lenvatinib加依维莫司和lenvatinib单药治疗转移性肾细胞癌效果好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2de45e3662c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687689, encodeId=10bc168e689b6, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=ESMO 18th：Xilonix单药治疗转移性结直肠癌是安全有效的, objectType=article, longId=72221, objectId=8f7de22214e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f7de22214e, replyNumber=0, likeNumber=77, createdTime=2017-04-08, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f7de22214e, moduleTitle=ESMO 18th：Xilonix单药治疗转移性结直肠癌是安全有效的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f7de22214e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687686, encodeId=a226168e6867f, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=抗癫痫药Aptiom单药治疗部分发作性癫痫在美国被批准上市, objectType=article, longId=55621, objectId=4e465562199, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e465562199, replyNumber=0, likeNumber=82, createdTime=2015-11-04, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e465562199, moduleTitle=抗癫痫药Aptiom单药治疗部分发作性癫痫在美国被批准上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e465562199)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687685, encodeId=c804168e68525, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=NEJM：Daratumumab单药治疗难治性骨髓瘤，安全性和疗效性良好, objectType=article, longId=55428, objectId=853555428cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=853555428cc, replyNumber=0, likeNumber=82, createdTime=2015-11-19, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=853555428cc, moduleTitle=NEJM：Daratumumab单药治疗难治性骨髓瘤，安全性和疗效性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=853555428cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687687, encodeId=7448168e68771, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Lancet HIV：蛋白酶抑制剂单药治疗可作为HIV感染的长期管理方法, objectType=article, longId=56277, objectId=7a42562e70e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a42562e70e, replyNumber=0, likeNumber=104, createdTime=2016-01-10, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a42562e70e, moduleTitle=Lancet HIV：蛋白酶抑制剂单药治疗可作为HIV感染的长期管理方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a42562e70e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687683, encodeId=d4a6168e68336, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=NEJM：Nivolumab和易普利姆玛联合治疗或单药治疗黑色素瘤, objectType=article, longId=51511, objectId=fde1515116c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fde1515116c, replyNumber=0, likeNumber=63, createdTime=2015-09-26, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fde1515116c, moduleTitle=NEJM：Nivolumab和易普利姆玛联合治疗或单药治疗黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fde1515116c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687681, encodeId=955a168e68180, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=NEJM：Nivolumab联合Ipilimumab用于晚期黑素瘤疗效优于单药治疗, objectType=article, longId=49754, objectId=de8f49e54b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de8f49e54b6, replyNumber=0, likeNumber=98, createdTime=2015-09-26, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de8f49e54b6, moduleTitle=NEJM：Nivolumab联合Ipilimumab用于晚期黑素瘤疗效优于单药治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de8f49e54b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687684, encodeId=a56d168e6844c, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=NEJM：Nivolumab和易普利姆玛联合或单药治疗未经治疗过的黑色素瘤, objectType=article, longId=52809, objectId=e69952809eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e69952809eb, replyNumber=0, likeNumber=72, createdTime=2015-12-20, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e69952809eb, moduleTitle=NEJM：Nivolumab和易普利姆玛联合或单药治疗未经治疗过的黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e69952809eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687679, encodeId=9957168e679be, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Oncol Lett：抗HER2单药治疗隐匿性乳腺癌1例, objectType=article, longId=44053, objectId=acca440536c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=acca440536c, replyNumber=0, likeNumber=53, createdTime=2015-01-16, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=acca440536c, moduleTitle=Oncol Lett：抗HER2单药治疗隐匿性乳腺癌1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=acca440536c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687682, encodeId=21bc168e682c1, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=母义明：维格列汀是2型糖尿病单药治疗后的又一选择？, objectType=article, longId=51345, objectId=0c1451345e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c1451345e1, replyNumber=0, likeNumber=119, createdTime=2016-01-12, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c1451345e1, moduleTitle=母义明：维格列汀是2型糖尿病单药治疗后的又一选择？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c1451345e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

单药治疗

2020-05-29

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Hepatology：乙肝肝移植术后恩替卡韦单药治疗长期预后

2017-08-05

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Opdivo单药治疗晚期肝癌是安全有效的（CheckMate 040）

2017-08-21

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Neurology：Preladenant单药治疗帕金森病III期失败

2017-07-28

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Am J Hematol：来那度胺单药治疗复发性/难治性套细胞淋巴瘤，安全且有效

2018-06-15

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

JAHA：磺脲类和二甲双胍单药治疗对心力衰竭风险的影响！

2017-12-27

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

UCB抗癫痫药Vimpat获欧盟批准单药治疗部分发作性癫痫，年销售峰值将达到12亿美元

2017-07-16

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

JCO：nivolumab单药治疗黑色素瘤安全性的Pooled分析

2017-07-23

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

LANCET：卡利拉嗪与利培酮单药治疗精神分裂症患者阴性症状的比较

2017-05-05

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Neurology：儿童失神癫痫患者的第二个单药治疗药物有哪些？

2017-08-27

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Arthritis Res Ther：塔西单抗单药治疗可以作为类风湿关节炎的二线治疗

2017-02-03

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Lancet Oncol：Lenvatinib加依维莫司和lenvatinib单药治疗转移性肾细胞癌效果好

2016-05-20

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

ESMO 18th：Xilonix单药治疗转移性结直肠癌是安全有效的

2017-04-08

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

抗癫痫药Aptiom单药治疗部分发作性癫痫在美国被批准上市

2015-11-04

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

NEJM：Daratumumab单药治疗难治性骨髓瘤，安全性和疗效性良好

2015-11-19

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Lancet HIV：蛋白酶抑制剂单药治疗可作为HIV感染的长期管理方法

2016-01-10

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

NEJM：Nivolumab和易普利姆玛联合治疗或单药治疗黑色素瘤

2015-09-26

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

NEJM：Nivolumab联合Ipilimumab用于晚期黑素瘤疗效优于单药治疗

2015-09-26

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

NEJM：Nivolumab和易普利姆玛联合或单药治疗未经治疗过的黑色素瘤

2015-12-20

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Oncol Lett：抗HER2单药治疗隐匿性乳腺癌1例

2015-01-16

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

母义明：维格列汀是2型糖尿病单药治疗后的又一选择？

2016-01-12

科室
- - 订阅+
  - 更多科室
工具
服务